Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Berg JM, Tymoczko JL, Stryer L. Biochemistry. 7th ed. New York: W.H. Freeman; 2012. xxxii, 1054, 43, 41, 48 p.
Kishnani PS, Austin SL, Abdenur JE, Arn P, Bali DS, Boney A, et al. Diagnosis and management of glycogen storage disease type 1: a practical guideline of the American College of Medical Genetics and Genomics. Genet Med. 2014;16:1–29.
Baumgartner MR, Saudubray J-M, Walter JH. Inborn metabolic diseases : diagnosis and treatment. Berlin/Heidelberg: Springer: Imprint: Springer; 2016.
Weinstein DA, Steuerwald U, De Souza CFM, Derks TGJ. Inborn errors of metabolism with hypoglycemia: glycogen storage diseases and inherited disorders of gluconeogenesis. Pediatr Clin N Am. 2018;65(2):247–65.
Saavedra H, editor. Management of glycogen storage disease type I & IIIf. Vitaflo metabolic RD summit. San Diego; 2020.
Ross KM, Ferrecchia IA, Dahlberg KR, Dambska M, Ryan PT, Weinstein DA. Dietary management of the glycogen storage diseases: evolution of treatment and ongoing controversies. Adv Nutr. 2020;11(2):439–46.
Institute of Medicine (U.S.). Panel on Macronutrients., Institute of Medicine (U.S.). Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Washington, DC: National Academies Press; 2005. xxv, 1331 p.
Shah KK, O’Dell SD. Effect of dietary interventions in the maintenance of normoglycaemia in glycogen storage disease type 1a: a systematic review and meta-analysis. J Hum Nutr Diet. 2013;26(4):329–39.
Derks TG, Martens DH, Sentner CP, van Rijn M, de Boer F, Smit GP, et al. Dietary treatment of glycogen storage disease type Ia: uncooked cornstarch and/or continuous nocturnal gastric drip-feeding? Mol Genet Metab. 2013;109(1):1–2.
Sidbury JB, Chen YT, Roe CR. The role of raw starches in the treatment of type I glycogenosis. Arch Intern Med. 1986;146(2):370–3.
Saudubray JM, Van den Berghe G, Walter J. Inborn metabolic diseases: diagnosis and treatment. 5th ed. Berlin: Springer; 2012. xxv, 656 p.
Blau N, Duran M, Gibson KM, Vici C D. Physician’s guide to the treatment and follow-up of metabolic diseases. New York: Springer; 2014.
Dahlberg KR, Ferrecchia IA, Dambska-Williams M, Resler TE, Ross KM, Butler GL, et al. Cornstarch requirements of the adult glycogen storage disease Ia population: a retrospective review. J Inherit Metab Dis. 2020;43(2):269–78.
Nalin T, Venema K, Weinstein DA, de Souza CF, Perry ID, van Wandelen MT, et al. In vitro digestion of starches in a dynamic gastrointestinal model: an innovative study to optimize dietary management of patients with hepatic glycogen storage diseases. J Inherit Metab Dis. 2015;38(3):529–36.
Vitaflo. A practical guide for overnight use of glycosade in hepatic glycogen storage disease. Bridgewater: Vitaflo USA, LLC; 2020.
Ross KM, Brown LM, Corrado MM, Chengsupanimit T, Curry LM, Ferrecchia IA, et al. Safety and efficacy of chronic extended release cornstarch therapy for glycogen storage disease type I. JIMD Rep. 2016;26:85–90.
Kishnani PS, Austin SL, Arn P, Bali DS, Boney A, Case LE, et al. Glycogen storage disease type III diagnosis and management guidelines. Genet Med. 2010;12(7):446–63.
Ross KM, Brown L, Corrado MM, Chengsupanimit T, Curry LM, Ferrecchia IA, et al. Safety and efficacy of long-term use of extended release cornstarch therapy for glycogen storage disease types 0, III, VI, and IX. J Nutr Ther. 2015;4(4):137–42.
Olgac A, Inci A, Okur I, Biberoglu G, Oguz D, Ezgu FS, et al. Beneficial effects of modified Atkins diet in glycogen storage disease type IIIa. Ann Nutr Metab. 2020;76(4):233–41.
Francini-Pesenti F, Tresso S, Vitturi N. Modified Atkins ketogenic diet improves heart and skeletal muscle function in glycogen storage disease type III. Acta Myol. 2019;38(1):17–20.
Marusic T, Zerjav Tansek M, Sirca Campa A, Mezek A, Berden P, Battelino T, et al. Normalization of obstructive cardiomyopathy and improvement of hepatopathy on ketogenic diet in patient with glycogen storage disease (GSD) type IIIa. Mol Genet Metab Rep. 2020;24:100628.
Steunenberg TAH, Peeks F, Hoogeveen IJ, Mitchell JJ, Mundy H, de Boer F, et al. Safety issues associated with dietary management in patients with hepatic glycogen storage disease. Mol Genet Metab. 2018;125(1–2):79–85.
Herbert M, Pendyal S, Rairikar M, Halaby C, Benjamin RW, Kishnani PS. Role of continuous glucose monitoring in the management of glycogen storage disorders. J Inherit Metab Dis. 2018;41(6):917–27.
White FJ, Jones SA. The use of continuous glucose monitoring in the practical management of glycogen storage disorders. J Inherit Metab Dis. 2011;34(3):631–42.
Daublin G, Schwahn B, Wendel U. Type I glycogen storage disease: favourable outcome on a strict management regimen avoiding increased lactate production during childhood and adolescence. Eur J Pediatr. 2002;161(Suppl 1):S40–5.
Saunders AC, Feldman HA, Correia CE, Weinstein DA. Clinical evaluation of a portable lactate meter in type I glycogen storage disease. J Inherit Metab Dis. 2005;28(5):695–701.
Acknowledgments
Thank you to Sandy van Calcar of Oregon Health & Science University for her contributions to this chapter’s content in the first Edition of Nutrition Management of Inherited Metabolic Diseases.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sowa, M. (2022). Nutrition Management of Glycogen Storage Disease. In: Bernstein, L.E., Rohr, F., van Calcar, S. (eds) Nutrition Management of Inherited Metabolic Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-94510-7_26
Download citation
DOI: https://doi.org/10.1007/978-3-030-94510-7_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-94509-1
Online ISBN: 978-3-030-94510-7
eBook Packages: MedicineMedicine (R0)